These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis. Seppälä E; Nissilä M; Isomäki H; Nuotio P; Nykänen E; Laitinen O; Vapaatalo H Clin Rheumatol; 1985 Sep; 4(3):315-20. PubMed ID: 3864577 [TBL] [Abstract][Full Text] [Related]
3. [Prostaglandins E2 and F2 alpha concentrations in the synovial fluid in rheumatoid and traumatic knee joint diseases]. Egg D; Günther R; Herold M; Kerschbaumer F Z Rheumatol; 1980; 39(5-6):170-5. PubMed ID: 7415586 [TBL] [Abstract][Full Text] [Related]
4. Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. Egg D Z Rheumatol; 1984; 43(2):89-96. PubMed ID: 6730731 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of indomethacin, aspirin and certain other drugs on inflammations induced in rat and dog by carrageenan, sodium urate and ellagic acid. van Arman CG; Carlson RP; Risley EA; Thomas RH; Nuss GW J Pharmacol Exp Ther; 1970 Nov; 175(2):459-68. PubMed ID: 5481710 [No Abstract] [Full Text] [Related]
6. [Progress in inflammation applicable to chronic evolutive polyarthritis]. Willoughby DA; Giroud JP; Velo GP Brux Med; 1974 Mar; 54(3):135-8. PubMed ID: 4362561 [No Abstract] [Full Text] [Related]
7. Synovial fluid and serological changes ater treatment in arthritic diseases. Williamson N; Holt PJ Ann Rheum Dis; 1968 Sep; 27(5):477-8. PubMed ID: 5302910 [No Abstract] [Full Text] [Related]
12. Concentrations of lonazolac in serum and synovial fluid of patients with inflammatory or degenerate joint disease. Mayrhofer F; Thumb N Int J Clin Pharmacol Res; 1984; 4(6):415-7. PubMed ID: 6533085 [TBL] [Abstract][Full Text] [Related]
14. [Effect of indomethacin and diclofenac on plasma and synovial prostaglandins in patients with rheumatoid arthritis]. Szczepański L; Kowalewski J; Miturzyńska-Stryjecka H; Horubała-Bielak G Reumatologia; 1983; 21(2):149-56. PubMed ID: 6585872 [No Abstract] [Full Text] [Related]
15. Antibodies to pharmacologically active molecules: specificities and some applications of antiprostaglandins. Levine L Pharmacol Rev; 1973 Jun; 25(2):293-307. PubMed ID: 4581046 [No Abstract] [Full Text] [Related]
16. [Study on the changes in the synovial fluid in various arthritis]. Nagatomi H Igaku Kenkyu; 1966 Oct; 36(5):565-74. PubMed ID: 6009286 [No Abstract] [Full Text] [Related]
17. [Urate crystals in the synovial fluid in gouty arthritis]. Hannestad K Tidsskr Nor Laegeforen; 1966 Apr; 86(7):474-8. PubMed ID: 5913634 [No Abstract] [Full Text] [Related]
18. Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI). Schaller M; Stohl W; Benoit V; Tan SM; Johansen L; Ditzel HJ Biochem Biophys Res Commun; 2006 Oct; 349(2):838-45. PubMed ID: 16949042 [TBL] [Abstract][Full Text] [Related]
19. Separation and fractionation of hyaluronic acid from human synovial fluid on agarose gels. How MJ; Long VJ Clin Chim Acta; 1969 Feb; 23(2):251-6. PubMed ID: 5764903 [No Abstract] [Full Text] [Related]